← Leaderboards
Kenneth J Mandell
Layerbio, Inc.
$1,648,924
Attributed
$1,809,876
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $740.2K · FY2015–25$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,809,876 · 3
By mechanism
R44$1,225,362 · 1
R43$584,514 · 2
Top collaborators
- M. Elizabeth Fini1 shared
Others in their field
Top investigators on “Oryctolagus Cuniculus”
- Jaap Goudsmit · Beth Israel Deaconess Medical Center$44,131,193
- John P Moore · Weill Medical College Of Cornell Univ$37,533,312
- Peter Scott Heeger · Case Western Reserve University$27,118,531
- Dafna Bar-Sagi · State University New York Stony Brook$19,610,586
- Michael G Agadjanyan · Institute For Molecular Medicine$18,913,438
- Michael Welch · Washington University$18,835,712
Research focus
Oryctolagus CuniculusSafetyDrug KineticsAffectEyedropsDosePharmaceutical PreparationsClinical TrialsOperative Surgical ProceduresTissuesEnsureMedical DeviceAqueous HumorAnimalsLensMedication ComplianceImplantPolymersPre-ClinicalKineticsManufacturer NameRegimenTechnologyToxicology
Grant awards (6)
Clusterin Targeting Epitheliopathy for Dry Eye$321,904
R43 · FY2025 · EY · contact PI
Sustained Release Travoprost Implant for Treatment of Glaucoma$642,269
R44 · FY2019 · EY · contact PI
Sustained Release Travoprost Implant for Treatment of Glaucoma$97,917
R44 · FY2019 · EY · contact PI
Sustained Release Travoprost Implant for Treatment of Glaucoma$485,176
R44 · FY2018 · EY · contact PI
Drug-Eluting Intraocular Lens$238,192
R43 · FY2015 · EY · contact PI
Drug-Eluting Intraocular Lens$24,418
R43 · FY2015 · EY · contact PI